I fully expect, and I will not try to stop a biosimilar IV version of KEYTRUDA coming on to the marketplace.
Editor's note · Context
Lujan expresses expectation for biosimilar market entry post-patent expiration.
Share
More from Ben Ray Luján
Growing up on my family’s small farm in Nambé, I saw firsthand the hard work it takes to keep a farm running. Farmers and ranchers deserve access to federal conservation programs that work for them, especially as the climate crisis…
Protecting livestock across the state requires investing in proven methods — like the sterile fly technique — to prevent the further spread in the United States.
Instead of addressing the affordability crisis, my Republican colleagues are fueling Trump’s chaos and corruption.
We appreciate that bipartisan provisions have been included in the discussion draft and stand ready to work with Republicans to negotiate a bipartisan Farm Bill that both meets the moment and can be successful on the Senate Floor.





